|
|
DYD B-11
|
|
 |
CtdJhUoPrMrBie |
 |
429 |
|
 |
| I can't get through at the moment http://fittor.fun/tehvids/ redhot
Prosensa has fared better than Belgium's Cardio3 BioSciences, which priced its initial public offering in Europe in early July at the bottom of its hoped-for range and took a further knock from questions over its research, which it said were unfounded. |
|
 |
Christopher |
 |
2020-04-18 22:18:06 |
|
|
|
|
|
|
|
|
|
